PharmaTher Holdings Ltd. (OTC:PHRRF – Get Free Report) shares were down 6.1% during trading on Friday . The company traded as low as $0.15 and last traded at $0.16. Approximately 178,931 shares were traded during trading, an increase of 5% from the average daily volume of 169,752 shares. The stock had previously closed at $0.17.
PharmaTher Trading Down 6.1 %
The firm’s 50-day simple moving average is $0.15 and its 200 day simple moving average is $0.16.
About PharmaTher
PharmaTher Holdings Ltd., a specialty pharmaceutical company, develops and commercialize specialty pharmaceuticals exhibiting the adoption and permitting novel delivery methods to enhance patient outcomes. The company's product pipeline includes KETARX, a hydrochloride injection for the treatment of Parkinson's disease, Amyotrophic Lateral Sclerosis, complex regional pain and Rett syndrome, and anesthesia and procedural sedation, as well as Ischemia reperfusion injury.
See Also
- Five stocks we like better than PharmaTher
- Following Congress Stock Trades
- Why Dollar Tree’s Family Dollar Sale Could Spark a Comeback
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- JPMorgan: The ‘NVIDIA of Banking’ Poised for More Gains?
- What is a Low P/E Ratio and What Does it Tell Investors?
- Buy the Chewy Stock Reversal? Here’s Why Now Is the Time
Receive News & Ratings for PharmaTher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PharmaTher and related companies with MarketBeat.com's FREE daily email newsletter.
